Navigation Links
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Date:5/13/2009

deep domain knowledge in life sciences and information technology. The firm's investments in life sciences include: ArthroCare, Aspreva Pharmaceuticals Corporation (acquired by Galenica group, SWX: GALN), Cor Therapeutics (acquired by Millennium Pharmaceuticals), Corixa (acquired by GlaxoSmithKline, GSK), Coulter Pharmaceutical (acquired by Corixa Pharmaceuticals), Cubist Pharmaceuticals, Epicor Medical (acquired by St. Jude Medical, STJ), Inspire Pharmaceuticals (ISPH), IntraLase, Myogen, Spinal Dynamics (acquired by Medtronic, MDT), TheraSense (acquired by Abbott Labs, ABT) and Ventritex (acquired by St. Jude Medical, STJ).

About Polaris Venture Partners:

A national venture capital firm with over $3 billion under management, Polaris (www.polarisventures.com) invests in seed, early stage and growth equity businesses in the life science, technology, digital media, enertech and consumer sectors. Through a philosophy of lead investing and active, long-term partnering with entrepreneurs and management teams, Polaris has helped a number of companies achieve outstanding success. Among them are: Accordant Health Services, Acusphere, Advanced Inhalation Research (acquired by Alkermes), Alnylam Pharmaceuticals, Aspect Medical Systems, Cubist Pharmaceuticals, deCODE genetics, GlycoFi (acquired by Merck), Momenta Pharmaceuticals and TransForm Pharmaceuticals (acquired by J&J).

About PureTech Ventures

PureTech Ventures (www.puretechventures.com) is a Boston-based venture creation firm specializing in translating breakthrough research from top tier academic institutions into therapies that will impact human health. PureTech's senior partners include entrepreneurs and leaders from the top echelon of pharma, biotech and academia including Dr. Ronald Cape (founder, Cetus), Dr.
'/>"/>

SOURCE Follica Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
2. OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific
3. iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development
4. The Arcas Group Appoints Executive Vice President
5. Elsevier Health Sciences Appoints Dr. David Goldmann Editor-in-Chief of its First Consult Point of Care Resource
6. ALS Therapy Development Institute, the Worlds Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer
7. Nfocus Neuromedical Appoints Robert OHolla to Head Regulatory
8. Kendle Announces Departure of Senior Vice President and CFO Karl Buzz Brenkert III; Appoints Keith A. Cheesman as Successor
9. Vasogen Appoints Dr. Eldon Smith Chairman
10. DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance
11. Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... Corporation (Nasdaq: DNDN ) announced today that ... have exercised in full their option to purchase ... the public offering price of $24.75 per share. ... size of the offering to an aggregate of ... to receive net proceeds from the offering of ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer ... center in the,US, the Tulane Cancer Center, ... phase III clinical study of Alpharadin in ... cancer,(CRPC) that has metastasized to the skeleton. ... (ALpharadin in SYMptomatic Prostate CAncer) study is ...
(Date:12/10/2009)... (Nasdaq: DNDN ) announced today that it has ... its common stock at a price to the public ... the underwriters a 30-day option to purchase up to ... overallotments, if any. The offering is expected to ... conditions. ,, J. P. Morgan Securities Inc. and Deutsche ...
(Date:12/10/2009)... NEWCASTLE, United Kingdom, Dec. 10 ... North East England Stem Cell Institute (NESCI) ... first successful treatment of eight patients with ... patients, own stem cells without the need ... http://www.newscom.com/cgi-bin/prnh/20080422/CLTU133LOGO-a ) ,, LSCD is a ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4
(Date:12/11/2009)... studying how bacteria under stress collectively weigh and initiate ... into how humans make strategic decisions that affect their ... , Their study, published this week in the early ... National Academy of Sciences , was accomplished when the ... describe the complex interplay of genes and proteins that ...
(Date:12/11/2009)... an associate professor of anthropology at the University of ... Kenya to understand how violence shapes the health of ... of her and her colleagues, research," Documenting the health ... northern Kenya: A conceptual framework," is currently published in ... , in collaboration with the British medical journal the ...
(Date:12/11/2009)... Arno Motulsky, the senior editor of the 4th edition ... Human Genetics, was recently given the Victor A. McKusick ... contributions to the field of human genetics, was presented ... American Society of Human Genetics on 24 October 2009 ... Medicine and Genome Sciences at the University of Washington ...
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5UA-led study grapples with health effects of low-intensity warfare 2Mapping the Link Between Alcohol Cancer 60159 1Mapping the Link Between Alcohol Cancer 60159 2Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 1Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 2Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 3Dr Lawrence Brown Named President of the Child Neurology Foundation 60155 1Dr Lawrence Brown Named President of the Child Neurology Foundation 60155 2
... WALNUT CREEK, Calif. The U.S. Department of Energy Joint ... assembly of the soybean (Glycine max) genetic code, making ... new breeding strategies for one of the world,s most ... 70 percent of the world,s edible protein, but also ...
... 8, 2008 Animal feeding operations are an important ... carbon dioxideknown greenhouse gases. Recent inventories suggest that ... methane emissions. As a consequence, greenhouse gas emissions ... development and sustainability of animal production and technologies ...
... help clear the plaques in the brain associated with Alzheimer,s ... The plaques are known to lead to the progressive death ... of dementia. , Sodium valproate - which is marketed as ... at the University of Leeds to reactivate the body,s own ...
Other Biology News:DOE Joint Genome Institute completes soybean genome 2DOE Joint Genome Institute completes soybean genome 3Oil spray reduces greenhouse gas emissions from pig finishing barns 2Epilepsy drug shows potential for Alzheimer's treatment 2
Request Info...
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
Request Info...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Biology Products: